A Hinge Health Backer Sold $38.4 Million in Stock After a 101% Run

July 12, 2026 - 22:06

A major early backer of Hinge Health has sold a large chunk of stock, cashing in on the digital health company's massive rally. The insider liquidated roughly 426,000 shares at an average price of $90.21, netting about $38.4 million. The move comes on the heels of a staggering 101% gain in the company's stock price over the past twelve months.

Despite the sizable sale, the investor is not walking away from the table entirely. The filing shows they still hold a significant stake in the form of 12.2 million derivative securities. This structure allows the insider to maintain economic exposure to Hinge Health's future performance without holding the common shares directly. The sale appears to be a routine portfolio rebalancing or a profit-taking strategy following the stock's explosive run, rather than a vote of no confidence.

Hinge Health, which specializes in digital musculoskeletal care, has seen its valuation and stock price surge as the market increasingly embraces virtual healthcare solutions. The company's platform, which offers exercise therapy, education, and coaching for chronic joint and back pain, has gained traction with both employers and health plans looking to reduce costs. The insider's decision to lock in gains now, while keeping a large derivative position, suggests a belief that the company still has room to grow, even after its recent meteoric rise.